找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Oncology of CNS Tumors; Jörg-Christian Tonn,David A. Reardon,Manfred Westp Book 2019Latest edition Springer Nature Switzerland AG 2019 Bra

[复制链接]
查看: 51525|回复: 58
发表于 2025-3-21 18:24:32 | 显示全部楼层 |阅读模式
书目名称Oncology of CNS Tumors
编辑Jörg-Christian Tonn,David A. Reardon,Manfred Westp
视频video
概述Provides clear, up-to-date guidance on diagnosis and treatment of CNS tumors in adults and children.Reflects the impacts of advances in molecular neuropathology and tumor biology on clinical practice.
图书封面Titlebook: Oncology of CNS Tumors;  Jörg-Christian Tonn,David A. Reardon,Manfred Westp Book 2019Latest edition Springer Nature Switzerland AG 2019 Bra
描述.This book is an easy-to-use reference that provides ready guidance on the diagnosis and treatment of the full range of tumors of the central nervous system in adults and children. The new edition has been completely revised to reflect the continually evolving landscape of neuro-oncology and provide readers with a thorough update that will inform their clinical practice. Since the previous edition, molecular neuropathology has progressed considerably, leading to a new understanding of specific clinical entities with corresponding changes in treatment concepts.  Moreover, tumor biology has become better integrated with clinical neuro-oncology in truly translational efforts. These advances receive detailed attention. In addition, the structure of the book has been adapted to align with the revised 2016 version of the WHO Brain Tumor Classification. Once again, the contributors have been carefully selected as leading experts in the field. .Oncology of CNS Tumors. is already established as a widely used reference, and this new edition will provide optimal value for highly specialized comprehensive neuro-oncology centers as well as practicing clinicians and researchers..
出版日期Book 2019Latest edition
关键词Brain tumours; Nervous System; Neuro-oncology; Neurosurgery; Oncology; Brachytherapy; Glioma; Surgery; Low-g
版次3
doihttps://doi.org/10.1007/978-3-030-04152-6
isbn_ebook978-3-030-04152-6
copyrightSpringer Nature Switzerland AG 2019
The information of publication is updating

书目名称Oncology of CNS Tumors影响因子(影响力)




书目名称Oncology of CNS Tumors影响因子(影响力)学科排名




书目名称Oncology of CNS Tumors网络公开度




书目名称Oncology of CNS Tumors网络公开度学科排名




书目名称Oncology of CNS Tumors被引频次




书目名称Oncology of CNS Tumors被引频次学科排名




书目名称Oncology of CNS Tumors年度引用




书目名称Oncology of CNS Tumors年度引用学科排名




书目名称Oncology of CNS Tumors读者反馈




书目名称Oncology of CNS Tumors读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

1票 100.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-22 00:07:43 | 显示全部楼层
发表于 2025-3-22 01:26:37 | 显示全部楼层
Imaging of Central Nervous System Tumorsuch as vessel caliber MRI and machine learning techniques, and development of new PET tracers are adding to the spectrum of available study tools. Critical evaluation of how to apply and incorporate these techniques into clinical practice will be important.
发表于 2025-3-22 06:42:26 | 显示全部楼层
发表于 2025-3-22 09:36:00 | 显示全部楼层
发表于 2025-3-22 15:12:26 | 显示全部楼层
发表于 2025-3-22 20:52:33 | 显示全部楼层
发表于 2025-3-22 21:25:25 | 显示全部楼层
Glioblastoma occur at younger age and share a more favorable outcome. Histone mutations, mostly H3K27M, have been described in a subset of midline and thalamic gliomas characterized by poor prognosis. The standard of care for typical IDH wild-type glioblastoma comprises maximum safe resection as feasible follow
发表于 2025-3-23 05:11:44 | 显示全部楼层
Ependymomas and Tumors of the Ventricular Systemerns of molecular characteristics have led to further subdivisions so that clinical trials with new targeted therapies or simply treatment regimens with established modalities can be homogeneously stratified. At present, the available studies still support gross total resection as the most relevant
发表于 2025-3-23 09:25:58 | 显示全部楼层
Pituitary Adenomasxcept for prolactinomas, surgical resection is the first-line treatment for symptomatic adenomas. In case of residual disease, pharmacotherapy and/or radiotherapy may be necessary. Due to the potential complex character of pituitary adenomas, the patient care may require a multidisciplinary cooperat
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 15:45
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表